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Abstract
Background—Prior research links optimism to physical health, but the strength of the association
has not been systematically evaluated.
Purpose—The purpose of this study is to conduct a meta-analytic review to determine the strength
of the association between optimism and physical health.
Methods—The findings from 83 studies, with 108 effect sizes (ESs), were included in the analyses,
using random-effects models.
Results—Overall, the mean ES characterizing the relationship between optimism and physical
health outcomes was 0.17, p<.001. ESs were larger for studies using subjective (versus objective)
measures of physical health. Subsidiary analyses were also conducted grouping studies into those
that focused solely on mortality, survival, cardiovascular outcomes, physiological markers (including
immune function), immune function only, cancer outcomes, outcomes related to pregnancy, physical
symptoms, or pain. In each case, optimism was a significant predictor of health outcomes or markers,
all p<.001.
Conclusions—Optimism is a significant predictor of positive physical health outcomes.
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Introduction
Interest in the relationship between personality characteristics and physical health has increased
substantially over the past several decades. Within this larger framework, a number of studies
have explored the link between dispositional optimism (the generalized expectation that good
things will happen) and physical well-being. Many of these studies have shown optimism to
be protective. For example, research shows that optimistic people, compared to those more
pessimistic in outlook, report less pain [1–4], better physical functioning [5–8], experience
fewer physical symptoms [6,8–12], and are less likely to be rehospitalized following coronary
artery bypass surgery [13].
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Although research on optimism and health has flourished, there has been no systematic review,
qualitative or quantitative, of this specific literature. Thus, the nature of the association between
optimism and physical health has not been explicitly assessed. This is an important oversight
inasmuch as not all studies report significant associations (e.g., [14]). The purpose of the
present paper is to provide a quantitative, meta-analytic review of the research exploring links
between dispositional optimism and physical health.
Two other recent reviews are relevant here. First, Pressman and Cohen [15] provided a
qualitative review of the literature linking positive affect to health. Although positive affect
and optimism are related constructs, they are not the same [15,16]. Thus, the focus of the review
by Pressman and Cohen [15] and the present review are distinct. Additionally, their review
was qualitative; whereas, the present review is quantitative. The second review, by Chida and
Steptoe [17], examined quantitatively the association between positive psychological well-
being and mortality. The review by Chida and Steptoe [17] differs from the present review in
that they defined positive psychological well-being quite broadly, including variables such as
vitality, life satisfaction, and positive affect, in addition to optimism. Inasmuch as subanalyses
were not conducted on specific predictors, it is difficult to tell whether optimism alone predicts
health outcomes. Additionally, Chida and Steptoe [17] focused on only one outcome, mortality;
whereas, the present review focuses on multiple outcomes.
As stated, the primary aim of this paper is to assess the extent to which optimism is linked to
physical health outcomes (broadly defined). In addition, the meta-analysis was used to gather
information about two other areas of interest. First, we wanted to examine moderators of the
relation between optimism and physical health. The strength of the association between
optimism and health varies across studies. The meta-analysis was used to identify and evaluate
potential reasons for these differences.
One way to distinguish between the effect sizes (ES) of different studies is to take into account
the manner in which physical health is assessed. The term “physical health” is quite broad and
includes outcomes that reflect disease endpoints that are “softer” or “harder” in nature. For
example, softer endpoints would include self-reports of symptoms or a clinical judgment about
disease state; whereas, a harder endpoint might be mortality. Self-reported outcomes are very
subjective in nature and rely completely on the respondent as a source of information. As such,
these reports are influenced by a host of factors (e.g., memory biases) other than the underlying
disease state. They also share important method variance with the manner in which optimism
is assessed (i.e., via self-report). In contrast, harder disease endpoints primarily reflect
outcomes that are biological in nature or outcomes that can be objectively determined (such
as immune parameters or mortality). The present analysis assessed whether optimism is more
strongly related to subjective than objective physical health outcomes.
The studies reviewed differ in many ways, in addition to the type of endpoint that is assessed.
The design of the study could also affect the ES. A significant finding in a cross-sectional study
may or may not hold in a study using a prospective design that examines changes in the outcome
across time. One could argue that different types of designs also offer research evidence that
is more or less convincing, in that some study designs (e.g., prospective studies) generally offer
better evidence than do others (e.g., cross-sectional studies). Conducting separate analyses
aggregating studies based on study design could be a useful way to identify variations in the
ES of associations between optimism and physical health.
Studies also differ on the type of participants that were sampled. Some studies sampled
participants that were healthy throughout the study, while other studies sampled participants
that were either acutely or chronically ill at the beginning of the study or were categorized
according to some specific health condition, such as pregnancy. Still, other research sampled
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participants that were healthy at the beginning of the study, and these participants may or may
not have been healthy at the end of the study (e.g., epidemiological studies of mortality due to
certain diseases).
Additional analyses were conducted distinguishing between studies that used healthy
participants versus those that used “patient” samples, to discern whether sample type makes a
difference in the relationship between optimism and physical health. We define healthy
participants as those who had no known disease or health problem throughout the entire
duration of the study and patient participants as those who were categorized according to a
specific health condition by the end of the study (including research on survival and mortality).
Moreover, the studies included in the database were quite diverse, in terms of the types of
outcome measures that were used. Because of this, we also performed subanalyses on clusters
of studies that examined similar outcomes. For example, we separated studies that measured
physiological markers (such as intima-media thickness, blood pressure, glycosylated
hemoglobin, and immune markers) from studies that measured disease endpoints or survival
and mortality. We also conducted subanalyses on several subjective outcomes of interest. In
summary, subsidiary analyses were conducted on studies grouped according to whether they
focused on mortality, survival, cardiovascular outcomes, physiological markers (including
immune function), immune function only, cancer outcomes, outcomes related to pregnancy,
physical symptoms, or pain.
A final difference among studies concerns the manner in which optimism was measured. Many
of the studies used the Life Orientation Test (LOT, [18]) or the revised LOT (LOT-R, [19]) to
assess the positivity of the generalized outcome expectancies that people hold. Peterson and
Seligman [20] have approached optimism in terms of explanatory style, and the Attributional
Style Questionnaire (ASQ, [21]) and the Expanded Attributional Style Questionnaire (EASQ,
[22]) have been developed to assess optimism from this perspective. Still, other measures have
also been used. The differences in the measures used to assess optimism may also account for
some of the variability among the studies. Analyses were conducted to explore this possibility.
As noted, the meta-analysis had a further aim, in addition to evaluating the significance of
several moderator variables of interest. Specifically, it was used to gather information relevant
to an issue that has emerged within the literature on optimism, but which also has implications
for the link between optimism and physical health. That is, Scheier and Carver [18] initially
conceptualized dispositional optimism as being a single bipolar trait, with optimism at one end
and pessimism at the other. Most people working in the field still continue to construe optimism
and pessimism in this fashion and analyze their studies accordingly. However, a number of
researchers [23] have explored the possibility that optimism and pessimism are somewhat
distinct constructs. This view is consistent with the fact that scales of generalized optimism
are often shown to comprise two separate components [18,19,23,24]—one measuring the
person's expectancies for positive outcomes (i.e., his or her optimism) and one measuring the
person's expectancies for negative outcomes (i.e., his or her pessimism).
If optimism and pessimism are viewed as two separate constructs, it becomes possible to ask
which one has a greater impact on physical health. Perhaps effects found in the more numerous
“bipolar” studies really are only due to the toxic effects of pessimism or only to the protective
effects of optimism (see, e.g., Robinson-Whelen et al. [25]). Alternatively, perhaps both are
equally important. The questions being asked here are reminiscent conceptually of the question
that has arisen in the literature on affect, pertaining to whether it is better to construe positive
and negative affect as bipolar ends of the same dimension or better to construe them as two
independent, albeit correlated, dimensions (e.g., [26]). The questions are also related
conceptually to the ones asked in earlier research involving the Type A Behavior Pattern and
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the attempt to identify which of the Type A components was most predictive of heart disease
(e.g., Matthews et al. [27]). To provide evidence on this issue, studies providing separate
assessments of optimism and pessimism were analyzed separately for optimism effects and
pessimism effects, to determine if the two components were differentially related to health
outcomes.
Method
Literature Search and Selection of Studies
In order to identify studies to include in our review, we performed computerized literature
searches of the MedLINE and PsycINFO databases. These searches were performed through
April 2009 using combinations of the following keywords: optimism, explanatory style, Life
Orientation Test, Life Orientation Test-Revised, Attributional Style Questionnaire, Expanded
Attributional Style Questionnaire, immunity, HIV/AIDS, rheumatoid arthritis, lupus,
autoimmune, multiple sclerosis, pain, pregnancy, infertility, neoplasms, cancer,
cardiovascular, coronary, cardiac, heart, hypertension, ischemic heart disease,
atherosclerosis, endocarditis, cardiomyopathy, heart failure, cerebrovascular disease,
anemia, stroke, diabetes mellitus, renal disease, disease, osteoarthritis, tuberculosis,
respiratory, asthma, Huntington's disease, Alzheimer's, influenza, pneumonia, peptic ulcer,
sleep, illness, physical health, survival, mortality, and chronic disease. We then used the
ancestry method to locate studies that had not been identified in the computerized searches.
Finally, we hand-searched through the three journals in which we found the majority of the
articles published that included measures of optimism and physical health: Journal of
Personality and Social Psychology, Health Psychology, and Journal of Behavioral Medicine.
We did not locate any additional studies through our hand-search. We limited the search to
only those studies that were published in English-language peer-reviewed journals.
Unpublished data such as doctoral dissertations and conference abstracts were not included.
This search identified 132 studies that were considered for inclusion in the meta-analysis.
Studies were then searched to determine whether they met the following additional inclusion
criteria: (1) the study had to have a measure (or measures) of dispositional optimism (thus,
studies were omitted if the expectancies measured were not generalized in nature, but rather
limited to a particular domain or disease outcome, e.g., expectancies about how quickly life
would normalize following coronary artery bypass graft surgery); (2) the study had to include
a measure (or measures) of a physical health outcome; (3) the study had to have some type of
ES statistic (such as a correlation coefficient) or statistics that could be transformed to an ES
(e.g., t tests); and (4) the sample size had to be reported. We included studies with subjective
and/or objective health outcomes. Subjective health outcomes include physical symptom
reports, pain reports, and physician ratings of health status. Objective health outcomes include
objective health records, survival, immune parameters, and various other biological outcomes.
Since we were interested in the relationship between optimism and physical health, we did not
include studies that only assessed mental health parameters (e.g., distress or anxiety). Using
these criteria, 84 studies were included in our analyses, with a total of 108 ESs.
Coding
Each study was coded for the following participant characteristics: type of sample (e.g., healthy
participants, and cancer patients), mean age of the participants, gender percentages, and racial
and ethnic category percentages. The following methodological characteristics were coded:
date the study was published, design of the study, optimism measure(s) used, outcome measure
(s) investigated, and the nature of covariates included in the analyses (if any).
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A brief explanation of our coding of the study designs is warranted here. Although many of
the studies were described by their authors as prospective studies, we categorized many of
these author-identified prospective studies as longitudinal studies for the purposes of the meta-
analysis. Many of the authors described their studies as prospective when they measured
optimism and physical health across time without controlling for baseline physical health
measures. Following Cohen et al. [28], we consider a prospective study to be a form of
longitudinal study that assesses the associations between a predictor at one point in time and
an outcome at a later point, controlling for the association between predictor and outcome at
baseline. For the purpose of this meta-analysis, studies were only coded as prospective if they
included (a) data presented in the article indicating that the sample was equivalent in health at
the beginning of the study, or (b) baseline physical health was controlled for in the ES
calculation between optimism and the later physical health outcome, or (c) the sample started
out as healthy at the beginning of the study and developed subsequent illness or disease. In
many instances, we could not extract the previously described prospective ES information from
the information presented in the papers; rather, the data were often reported as measuring the
relevant variables across time without controlling for baseline physical health. Readers should
be aware that we used our coding scheme to classify studies in the tables that are presented,
and that our coding scheme may be at odds with the coding scheme used by the authors.
Calculation of Effect Sizes
We calculated ESs based on statistics published in the original reports. ESs are presented as
correlation coefficients (r) in the table. Not all studies presented correlations between optimism
and health outcomes, thus, other statistical information was converted to correlation
coefficients. Student t and F values were transformed into correlations using formulas provided
by Lipsey and Wilson [29]. If no statistics to calculate an ES were presented, we searched the
article for a relevant p value, from which, we calculated a t statistic and an requivalent [30] using
the formula: . Four studies reported odds ratios, which were converted
into correlation coefficients using the formula: r = (odds ratio − 1)/(odds ratio + 1) [31]. Two
studies reported only that their findings regarding optimism and health outcome were
nonsignificant and did not provide further information for calculating an ES. The results from
these studies were assigned an r of zero. This is a conservative approach as there is seldom
zero correlation between two constructs. If the article did not include an ES or information to
calculate an ES, the author of the study was contacted directly for the ES information. We
contacted 24 authors (three authors were contacted about more than one manuscript and several
ES possibilities). Twenty of the authors contacted replied that they would attempt to address
our request, two were unable to provide ES information due to no longer having access to the
data, 15 provided us with the ES information we requested, and three failed to respond
following several reminders after their initial agreement to provide the information.
Meta-analytic Procedures
We converted all test statistics into Fisher z scores before conducting the analyses. Mean ESs
were transformed back into rs for presentation after all analyses were conducted. Each study
contributed only one ES per analysis in order to maintain the assumption of statistical
independence [32]. When a study contained more than one ES, such as longitudinal studies
with multiple follow-up points on the same outcome, we computed the average ES to avoid
violating the assumption of statistical independence. We used a Statistical Package for the
Social Sciences macro, MEANES [29], to conduct the meta-analyses.
Several different sets of analyses were conducted. In order to aggregate across studies, the sign
of the ESs were changed as needed to make them consistent across studies. Such
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transformations were necessitated because some of the health outcomes measured (e.g., pain)
were negative in nature and some of the outcomes measured (e.g., survival time) were positive
in nature. The first planned analyses were conducted on the overall relationship between
optimism and physical health, aggregating across all studies. We expected that optimism would
be significantly related to physical health and that the ESs in this analysis would be
heterogeneous.
The second set of analyses categorized studies in terms of the kind of physical health outcome
examined (i.e., whether the outcome studied was objective or subjective in nature). We
expected that optimism would be more strongly related to subjective measures of physical
health than objective measures, which reflected harder disease endpoints.
Third, we conducted analyses aggregating studies based on the study design (cross-sectional,
longitudinal, or prospective), as we expected that study design would moderate the relationship
between optimism and physical health.
We then conducted analyses aggregating studies based on sample type (healthy versus patient).
We also conducted separate analyses for studies that looked only at mortality, survival,
cardiovascular outcomes, physiological markers (including immune function), immune
function only, cancer outcomes, physical symptoms, pain, or only at outcomes related to
pregnancy.
We also performed analyses aggregating studies based on the type of optimism measure used.
Different measures of optimism have emerged from somewhat different theoretical
perspectives [33], and it is possible that these differences in measurement instruments may
moderate the relationship between optimism and physical health. Specifically, we separated
analyses based on whether the studies used (a) LOT or LOT-R, (b) ASQ or EASQ, or (c) one-
item measures of optimism.
Finally, we conducted analyses comparing ESs for those studies providing separate
assessments of optimism and pessimism. These analyses were conducted as it remains unclear
whether heightened optimism is protective, heightened pessimism is risk-enhancing, or if both
factors are important in understanding links to physical well-being.
Each ES was weighted by sample size before conducting analyses, as studies that have a larger
sample size provide a more accurate estimate of the true population parameter [29]. We
calculated both an unweighted mean ES and a sample size-weighted mean ES for each analysis.
There were no differences between the mean ESs for the analyses, thus, we only present the
weighted mean ES in the results. Analyses were conducted using a random-effects model
[29,34,35], as our goal was to be able to generalize the findings beyond the studies included
in the meta-analysis. Random-effects models calculate means and confidence intervals that
generalize to all studies in a research area, as opposed to fixed effects models which cannot be
generalized to the entire domain of studies [34]. The random-effects model enables
generalization beyond the observed studies because the model assumes that population
parameters vary between studies and attempts to estimate this variance. This estimated variance
is combined with the subject-level sampling error and is used to compute standard errors and
confidence intervals. With more variance, the confidence intervals calculated using a random-
effects model will be larger than those calculated using a fixed effects model. Using a random-
effects model, though, provides a conservative test of significance of combined effects sizes;
whereas, inappropriately applying a fixed effects model when it is not appropriate can yield
erroneously narrow confidence intervals [34,35].
Primary analyses used unadjusted ESs to estimate the association between optimism and health.
We used unadjusted ESs because that was the only information available for the majority of
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effects. Although adjusted ESs were sometimes available, the primary analyses used only
unadjusted ESs, in order to use the same metric for all effects that were included. Subsidiary
analyses were also conducted, however, to determine whether ESs were also significant when
only including effects that were adjusted for covariates. To do this, effects were placed into
one of three categories: those that did not adjust for covariates, those that were adjusted for
demographic and/or health risk covariates, and those that were adjusted for one or more
psychosocial covariates such as depression or negative affectivity (62.9%, 19%, and 18.1% of
the total effects available for analysis, respectively). The overall analysis was then repeated,
breaking effects down into these three categories. Similar subsidiary analyses were conducted
stratifying effects according to whether they reflected a subjective health outcome or an
objective health outcome.
Additional Analyses
We conducted t tests and F tests that paralleled the aforementioned meta-analyses. First, we
compared ESs between objective and subjective measures of physical health to investigate
whether the type of health outcome studied results in different ESs. Comparisons also were
conducted after aggregating the studies by design (cross-sectional, longitudinal, and
prospective). Similarly, we compared healthy versus patient samples to discern whether type
of participant sampled in the studies might result in significantly different ESs. We also
compared ESs between studies using different measures of optimism and studies that measured
optimism and pessimism separately. Finally, we conducted F tests to determine if ES varied
as a function of whether the effect was adjusted for covariates or not.
Results
The Appendix provides a descriptive summary of each study utilized in the meta-analysis
including the total number of participants, sample type, optimism measure used, physical health
outcome investigated, and ES. These data are split according to whether the physical health
outcome assessed was objective or subjective in nature. Some studies are listed more than once,
as they reported multiple correlations between optimism and physical health measures. The
majority of the studies consisted of longitudinal (35% of the sample) and prospective designs
(28% of the sample). The remainder of studies included was cross-sectional (35% of the
sample). Some of the longitudinal and prospective studies also included cross-sectional data.
Forty-four of the ESs (38%) involve correlations between optimism and objective physical
health outcomes, and 73 of the ESs (62%) involve correlations between optimism and
subjective physical health outcomes. The majority of studies (78%) used the LOT [36] or LOT-
R [30] to measure optimism. When judging and interpreting ESs, 0.10 is considered a small
effect, 0.30 is considered a medium effect, and 0.50 is considered a large effect [37].
Overall Analysis of Effect Sizes for Optimism and Physical Health
The first analysis included the ES of all studies with the goal of providing an overall mean ES
of the relationship between optimism and physical health. This analysis revealed a mean ES
of 0.17 (K=108; N=30,133; 95% CI=0.15 to 0.20). Thus, optimism was significantly related
to physical health outcomes based on all the studies examined (p<.001). Not surprisingly, the
analysis showed that the test of homogeneity (Q=343.49, p=.000) was also significant,
suggesting that the ESs in the overall analysis are heterogeneous. Accordingly, the planned
moderator analyses were conducted in order to identify the source of some of this heterogeneity.
Moderators of the Relationship Between Optimism and Physical Health
Objective and Subjective Measures of Physical Health—The mean ES for optimism
and subjective measures of physical health outcomes was 0.21 (K=65; N=11,772; 95% CI=0.18
to 0.25), and the mean ES for optimism and objective measures of physical health outcomes
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was 0.11 (K=43; N=18,361; 95% CI=0.09 to 0.14). Thus, ESs for both subjective and objective
health outcomes were significantly different from zero (both p<.001). The t test conducted to
compare ESs for subjective and objective health outcomes revealed that the mean ES for
objective measures was significantly smaller than the mean ES for subjective measures (t (106)
=−2.89, p=.005). Thus, the type of health outcome assessed moderates the relationship between
optimism and good health.
Study Design—We conducted analyses for optimism and health after stratifying by study
design. The mean ES for optimism and health outcomes was 0.22 (K=37; N=8,443; 95%
CI=0.18 to 0.26) for cross-sectional designs, 0.18 (K=38; N=5,692; 95% CI=0.13 to 0.22) for
longitudinal designs, and 0.12 (K=33; N=15,998; 95% CI=0.09 to 0.15) for prospective
designs. Each of the mean ESs was significantly different from zero (all p<.001). We tested
the significance of the differences between ESs using analysis of variance. This analysis did
not reveal any significant differences [F (2, 105)=1.73, p=.18].
Inspection of the mean ESs, however, reveals that the differences are ordered in the expected
direction, with the ES for prospective studies being the lowest. Consequently, a secondary
analysis was conducted. For this analysis, cross-sectional and longitudinal studies were
combined, because they suffer conceptually from the same set of limitations and compared to
studies that used prospective designs. The mean ES for optimism and health outcomes for
cross-sectional and longitudinal studies combined was 0.20 (K=75; N=14,135; 95% CI=0.17
to 0.23). The mean ES for cross-sectional and longitudinal studies combined was not
significantly larger than the mean ES (0.12) for prospective studies (t (106)=1.70, p=.09, 95%
CI=−0.01 to 0.11), although the difference approached significance.
Type of Sample—For this set of analyses, we separated the analyses based on the type of
participant sampled in the studies (i.e., healthy versus patient) to discern whether sample type
was a moderator. For the studies using healthy samples, the mean ES for the relationship
between optimism and health was 0.15 (K=39; N=22,369; 95% CI=0.12 to 0.18). For studies
using patient samples, the mean ES for the relationship between optimism and health was 0.19
(K=69; N=7,864; 95% CI=0.16 to 0.23). Both ESs were significantly different from zero (both
p<.001). The follow-up t test indicated that the mean ES for healthy samples was not
significantly different than the mean ES for patient samples [t (106)=−1.09, p=.27], indicating
that sample type is not a moderator of the relationship between optimism and health.
Separate analyses were also performed for studies that looked only at the following: mortality,
survival, cardiovascular outcomes, physiological markers (including immune function),
immune function only, cancer outcomes, physical symptoms, pain, or outcomes related to
pregnancy. For purposes of these analyses, we kept the studies with prospective designs
separate from the studies with cross-sectional and longitudinal designs but combined the latter
two groups. These analyses showed that optimism was linked to the vast majority of health
outcomes that were assessed including mortality and survival (see Table 1). Only four analyses
failed to find an ES greater than zero, and two of these four were close to being significant
(i.e., those involving cross-sectional and longitudinal studies of immune function (p=.07), and
those involving prospective studies of cancer outcomes (p=.053)). The link between optimism
and health seemed most tenuous for prospective studies of pain (p=.18).
Type of Optimism Measure—Analyses were conducted for studies using different
measures of optimism: the LOT or LOT-R, ASQ or EASQ, and one-item measures of optimism.
The mean ES for optimism and health using the LOT or LOT-R as the measure of optimism
was 0.17 (K=94, N=22,413, 95% CI=0.14 to 0.19). The mean ES was 0.28 (K=5; N=471; 95%
CI=0.05 to 0.47) for those studies using the ASQ or EASQ and 0.31 (K=4; N=4,137; 95%
CI=0.16 to 0.44) for those using one-item measures of optimism. All ESs were significantly
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different from zero (all p<.01). The means ESs for the different types of optimism measures
were not significantly different from each other (F (6, 96)=1.25, p=.29), indicating that type
of optimism measure is not a moderator of the relationship between optimism and health
outcomes.
Optimism Versus Pessimism—Analyses were done on those studies that assessed
optimism and pessimism separately, in order to assess the strength of association of each
element to health outcomes. The mean ES between the optimism component by itself and health
was 0.14 (K=16; N=11,243; 95% CI=0.08 to 0.20). The mean ES between the pessimism
component and health was 0.18 (K=17; n=7,666; 95% CI=0.12 to 0.24). The mean ES for each
component was significantly different from zero (both p<.001). Although the mean ES for the
pessimism component was larger than the mean ES for the optimism component, a follow-up
t test revealed no significant difference between the two means.
Unadjusted Versus Adjusted Effect Sizes—To determine whether ESs differed
depending on whether the effects were adjusted for covariates or not, effects were grouped into
one of three categories: those that were unadjusted for covariates, those that were adjusted for
demographic and/or health risk covariates, and those that were adjusted for psychosocial
covariates. In terms of the overall analysis, the mean ES between optimism and health for
unadjusted effects was 0.18 (K=66; N=8,493; 95% CI=0.13 to 0.19). The mean ES for effects
adjusted for demographic and/or health risk covariates was 0.16 (K=20; N=8,312; 95% CI=0.11
to 0.22). The mean ES for effects adjusted for psychosocial covariates was 0.20 (K=19;
N=7,767; 95% CI=0.13 to 0.26). All ESs were significantly different from zero (all p<.001).
The mean ESs did not differ significantly from each other (F (2, 102)=1.25, p=.29).
Two further analyses were also performed—one including effects that involved subjective
outcomes and one including effects that involved objective outcomes. With respect to effects
involving subjective outcomes, the mean ES between optimism and health for unadjusted
effects was 0.20 (K=42; N=5,255; 95% CI=0.17 to 0.23). The mean ES for effects adjusted for
demographic and/or health risk covariates was 0.18 (K=10; N= 809; 95% CI=0.05 to 0.30).
The mean ES for effects adjusted for psychosocial covariates was 0.24 (K=11; N=5,574; 95%
CI=0.14 to 0.32). Each of these ESs was significantly different from zero (all p≤.005). The
mean ESs did not differ significantly from each other (F (2, 60)=1.15, p=.32).
With respect to effects involving objective outcomes, the mean ES between optimism and
health for unadjusted effects was 0.08 (K=24; N=8,493 95% CI=0.06 to 0.10). The mean ES
for effects adjusted for demographic and/or health risk covariates was 0.24 (K=10; N=7,503;
95% CI= 0.14 to 0.34). The mean ES for effects adjusted for psychosocial covariates was 0.14
(K=8; N=2,193; 95% CI=0.06 to 0.22). All ESs were significantly different from zero (all p<.
001). The mean ESs did not differ significantly from each other (F (2, 39)=2.39, p=.11).
Because of the special interest in the relationship between optimism and negative affectivity
that has arisen in the literature (e.g., [38]), one final analysis was conducted. For this analysis,
effects were included only if the effect was adjusted for some variant of negative affectivity
(i.e., for measures of neuroticism, negative affectivity, or depression). This analysis produced
a mean ES of 0.20 (K=10; N=1,848; 95% CI=0.06 to 0.32). This ES was significantly different
from zero (p<.005).
Discussion
This quantitative review summarizes the findings from 84 studies that tested the relationship
between optimism and physical health outcomes. In the aggregate, these studies strongly
suggest that optimism is a significant predictor of physical health. The ES for the overall
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analysis was in the small to moderate range, using the framework developed by Cohen and
Cohen [37]. This finding is important because not all of the prior research on optimism and
physical health has produced significant relationships [14]. The results from the overall
analysis help to document the positive role that optimism plays in physical well-being.
Also noteworthy is the fact that the strength of the relationship between optimism and health
was moderated by the nature of the outcome that was assessed. That is, results revealed that
the mean ES for studies using subjective measures to assess health outcomes was significantly
higher than the mean ES for studies using objective measures. Indeed, the mean ES for
subjective outcomes was nearly twice as high as the mean ES for objective measures.
As defined in the present study, subjective health measures were largely those that reflected
self-reports of physical symptoms or pain (but included physician ratings of disease as well).
Over the past several decades, self-report measures of health have come under increasing
scrutiny, for at least a couple reasons. First, when psychosocial predictors and health outcomes
are both assessed via self-reports, they share common method variance, and this shared method
variance may lead to inflated associations. Second, numerous authors have argued that self-
reports might be contaminated by certain psychosocial factors, most notably, neuroticism
[39,40]. The argument here is that nuisance factors like neuroticism relate to self-reports of
disease not because of any real association with the underlying disease process but because of
reporting biases and perceptional distortions. To the extent that characteristics like neuroticism
are correlated with the psychosocial predictor variables of interest, inflated associations with
health can result.
The fact that the mean ES for studies using subjective measures of health was higher than the
mean ES for studies using objective measures of health is consistent with the concern about
self-report measures. It is also important to realize, however, that even though the mean ES
for studies using objective measures was lower, it was still statistically significant.
Additionally, separate analyses conducted on studies focusing exclusively on survival,
mortality, cardiovascular outcomes, physiological markers (including immune function),
immune function only, cancer outcomes, and pregnancy outcomes all documented significant
effects between optimism and health. Thus, optimism still predicts health outcomes, even when
harder disease endpoints and direct markers of underlying physiologic state are used.
There was no moderator effect for study design in the present set of analyses. This finding is
somewhat surprising. Because prospective designs explicitly take baseline health into account,
they focus on changes in health over time, and as such, provide a direct measure of the temporal
association between variables. We anticipated that these differences between designs would
result in smaller mean ESs for prospectively designed studies. This was not the case. Even so,
we still believe that prospective studies are preferred. Prospective studies are the only ones that
are able to eliminate an explanation based on reverse causality. Thus, the advantage held in
this regard by prospective studies is far from trivial.
We also considered that ESs for the association between optimism and physical health might
differ depending on the type of population that is sampled. This was not the case. Although
the ES for studies using patient populations was larger than the ES for studies using healthy
populations, the difference was small and nonsignificant.
Neither were there any differences between ES as a function of the type of optimism measure
that was used. This suggests that choice of assessment instrument may not matter. We should
note, however, that the majority of studies reported in the literature used either the LOT or
LOT-R to assess optimism. This is likely due to the fact that these scales are easy for participants
to complete. They also allow for the separate measurement of optimism and pessimism,
depending on how the scale is scored. This is a capability that one-item scales do not have.
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Thus, there are reasons why these scales have been used so much. Continued use of the LOT-
R (the newer preferred version) would allow for the greatest comparability with the prior
research that has been done.
Primary analyses were based on unadjusted ESs. While informative, unadjusted effects do not
rule out the possibility that the effects were due in fact to some unmeasured factor that is
correlated with optimism. For example, perhaps persons who are healthier are more optimistic
and that it is differences in health that are driving the effects, not differences in optimism.
Similarly, the argument has been made [38] that optimism effects are really due to the
confounding with neuroticism or negative affectivity. Analysis of ESs adjusted for relevant
covariates could help mitigate some of these concerns.
Subsidiary analyses of major findings revealed that significant ESs were obtained even when
ESs were adjusted for relevant demographic factors, health status and health risk factors, and
relevant psychosocial factors. Indeed, there were no significant differences between adjusted
and unadjusted ESs in any of the analyses that were conducted. Perhaps most noteworthy was
the finding that a significant ES emerged for optimism even from those studies that specifically
adjusted their effects for negative affectivity. This strongly suggests that the effects of optimism
are independent of the effects of negative affectivity. More generally, it suggests that
dispositional optimism is a significant predictor of variations in physical health and biologic
markers of health, even when traditional risk factors and relevant psychosocial factors are taken
into account. As such, dispositional optimism provides value added.
Our final issue has to do with the relative potency of optimism and pessimism, if the two
components are viewed as separate rather than comprising the polar ends of a single
unidimensional construct. Although the statistical test comparing the optimism and pessimism
components was not significant, the mean ES for the pessimism component was larger than
the mean ES for the optimism component. This fact, coupled with the small number of studies
involved in the comparison, suggests that the question should remain open. It may well be the
case that it is the presence or absence of pessimism that is important in determining physical
health outcomes rather than the presence or absence of optimism. Scheier et al. [19] have
explicitly suggested that primary analyses involving optimism and pessimism be conducted
using an overall composite score, treating the variables as bipolar opposites. They also
suggested that secondary analyses of data sets be done to explore whether one component was
more or less toxic (or more or less protective) than the other. Given that this issue has yet to
be definitively resolved, routinely conducting and reporting secondary analyses of data sets
separating optimism and pessimism by component would still seem warranted.
Limitations
Every data analytic plan or research strategy has its limitations, and meta-analysis is no
exception. These limitations need to be borne in mind when evaluating the conclusions that
can be drawn from the results presented. First, the search for studies has to end at some point
in time; even the research literature that the review captures is dynamic. Additional studies
will always be added to the literature. In this sense, all attempts to characterize the literature
are necessarily out of date.
A second limitation of meta-analysis has to do with aggregating research findings based on
multivariate relationships. There are two issues here. The first has to do with the paucity of
studies that include covariates in analyses. In the majority of studies that we located, unadjusted
effects were all that were reported, and less than 20% contained psychosocial covariates.
Additionally, the information needed to construct inverse variance weights is often not
available in the published manuscript [29]. It is difficult to estimate the independent effect of
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some factor of interest when relevant covariates are not measured or are reported upon in a
manner from which ESs cannot be extracted.
The second problem has to do with the difficulty interpreting ESs from multivariate analyses
even when the data are available. That is, the field has not agreed upon set of demographic,
health risk, or psychosocial factors to include in analyses. As a result, the ES statistics are
contingent on very different covariates from study to study. This makes it difficult to know
whether the effects of a target variable, e.g., optimism, are independent of specific covariates,
e.g., age. In this case, an analysis was performed aggregating only studies that include a
measure of affectivity, because the confounding of optimism and negative affectivity has been
explicitly discussed in the literature [38]. However, it is not feasible to do this for every
covariate measured. To do so would yield a set of results that would be exceedingly complex
and likely too fragmented to understand fully. Thus, although analyses of ESs based on
multivariate associations have benefits (i.e., they can tell you in general whether a target
variable provides value added), they also have drawbacks.
A third limitation has to do with the fact that the current meta-analysis used correlations across
studies to calculate ESs. Use of this technique precluded the possibility of including in the
analysis studies that report interactions between optimism and some other psychosocial
variable. Although there are very few studies that explore interactions of this type, including
them in the meta-analysis might have yielded a more complex picture of the relationship
between optimism and health.
Looking to the Future
The present meta-analysis identified a number of studies that examined links between optimism
and physical health outcomes and underlying biologic states. The nature of the studies included
and the meta-analyses performed on the outcome of those studies can be used to help inform
future research activity in this area. In general, it is clear from this review that optimism is
related to physical health. It is also clear that the link between optimism and health is stronger
for subjective health outcomes than for objective health outcomes. We do not need more studies
to document these basic effects.
On the other hand, there are at least three issues or concerns that the present meta-analysis
raised toward which future research might be directed. The first has to do with the continued
effort to tease apart the effects of optimism from related constructs. It was noteworthy to us
that so few studies included psychosocial covariates. Although the data suggested that
optimism is linked to health, independent of other relevant psychosocial characteristics, the
analyses were based on a limited set of studies. Thus, it will be important for future studies to
include measures of related concepts and continue the effort to distinguish which effects are
due to what. It will also be important to report findings in such a manner that ESs can be easily
estimated.
We should explicitly note that this recommendation is not limited to research focusing on the
effects of optimism. The same strategy should be employed whenever psychosocial predictors
are being examined, particularly so when those psychosocial predictors involve characteristics
of the person. Thus, studies that focus on depression, positive affect, or whatever variable
should also include relevant psychosocial covariates, so that the effects of variables other than
optimism can be distinguished as well. As already discussed, the importance of including
covariates in research on optimism has been primed because of the discussion in the literature
of the association between optimism and negative affectivity [38]. Although we have not
systematically examined the literature, it would not be surprising to learn that even fewer
studies of other psychosocial variables have included psychosocial covariates in their designs.
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Second, very few studies have attempted to capture the underlying pathways by which
optimism impacts disease and health. To identify such pathways, studies are needed that assess
optimism, the suspected underlying pathways, and relevant disease endpoints and health
outcomes. Relevant statistical analyses then have to be performed to determine whether those
pathways provide a viable explanation for the optimism-disease link. Such studies are
complicated and time consuming to enact, which no doubt explains why so few studies of this
type exist. Still the relevant studies are conspicuously lacking from the available database and
need to be conducted in the future.
Finally, attention still needs to be given to the relative toxicity of optimism versus pessimism.
Although not statistically significant, ESs for the pessimism component were larger than the
ESs for the optimism component. Very few studies have conducted analyses that enable the
relative potency of these two components to be evaluated, and more studies are critically
needed. The answer to the question of which component is more toxic has implications for not
only how we understand the manner in which expectancies impact health but also on the kinds
of interventions that are created to help people maintain better health.
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